China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SHE:000999)
China flag China · Delayed Price · Currency is CNY
25.91
-0.15 (-0.58%)
Apr 30, 2026, 3:04 PM CST

SHE:000999 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
31,77030,49426,46623,83717,41114,825
Other Revenue
1,1091,1091,151901.47667.99719.33
32,87931,60327,61724,73918,07915,544
Revenue Growth (YoY)
20.98%14.43%11.63%36.84%16.31%13.98%
Cost of Revenue
14,80514,56713,45211,6758,3546,561
Gross Profit
18,07417,03614,16413,0649,7258,984
Selling, General & Admin
11,81010,9688,8608,4896,1355,992
Research & Development
1,4651,268801.75714.5593.94560.2
Other Operating Expenses
416.14334.16229.73262.72207.05204.39
Operating Expenses
13,75712,6069,9749,5216,9426,770
Operating Income
4,3164,4304,1913,5432,7842,214
Interest Expense
-128.03-117.62-80.04-80.78-21.23-14.18
Interest & Investment Income
99.7290.32133.9125.1118.11101.08
Currency Exchange Gain (Loss)
-2.75-2.755.482.5-56.25-12.89
Other Non Operating Income (Expenses)
-38.31-32.7-15.21-17.44-4.11-1.11
EBT Excluding Unusual Items
4,2474,3674,2353,5722,8202,287
Impairment of Goodwill
-----65.51-44.24
Gain (Loss) on Sale of Investments
284.09227.4168.2-28.632.585.04
Gain (Loss) on Sale of Assets
6.356.531.430.812.280.85
Asset Writedown
-74.29-50.18-19.67-82.35-34.3-8.1
Other Unusual Items
330.44312.99278.8292.43237.69202.96
Pretax Income
4,7944,8644,5943,7542,9632,444
Income Tax Expense
749.91698.12815.87580.97466.43345.41
Earnings From Continuing Operations
4,0444,1663,7783,1732,4972,099
Minority Interest in Earnings
-817.22-744.96-409.85-320.55-48.21-43.49
Net Income
3,2273,4213,3682,8532,4492,055
Net Income to Common
3,2273,4213,3682,8532,4492,055
Net Income Growth
-1.45%1.58%18.05%16.50%19.16%28.65%
Shares Outstanding (Basic)
1,6621,6611,6671,6561,6691,654
Shares Outstanding (Diluted)
1,6621,6611,6671,6631,6691,654
Shares Change (YoY)
-0.52%-0.40%0.25%-0.33%0.90%-0.15%
EPS (Basic)
1.942.062.021.721.471.24
EPS (Diluted)
1.942.062.021.721.471.24
EPS Growth
-0.93%1.98%17.76%16.89%18.10%28.83%
Free Cash Flow
4,2374,2423,6123,3352,0551,012
Free Cash Flow Per Share
2.552.552.172.001.230.61
Dividend Per Share
1.0401.0401.0150.8870.5920.505
Dividend Growth
2.42%2.42%14.41%49.99%17.26%70.53%
Gross Margin
54.97%53.91%51.29%52.81%53.79%57.79%
Operating Margin
13.13%14.02%15.17%14.32%15.40%14.24%
Profit Margin
9.81%10.82%12.20%11.53%13.54%13.22%
Free Cash Flow Margin
12.89%13.42%13.08%13.48%11.37%6.51%
EBITDA
5,4445,4604,8294,2283,2512,643
EBITDA Margin
16.56%17.28%17.48%17.09%17.98%17.00%
D&A For EBITDA
1,1281,030638.08685.71467.17429.17
EBIT
4,3164,4304,1913,5432,7842,214
EBIT Margin
13.13%14.02%15.17%14.32%15.40%14.24%
Effective Tax Rate
15.64%14.35%17.76%15.47%15.74%14.13%
Revenue as Reported
32,87931,60327,61724,73918,07915,544
Advertising Expenses
-1,316754.25660.33543.92578.72
Source: S&P Global Market Intelligence. Standard template. Financial Sources.